Industry: Medical Devices & Consumables
Published Date: 2024-04-25
Pages: 105 Pages
Report ld: 3077188
Request Sample
Customized Report
The global Asthma Inhalers market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Asthma Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Asthma Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Asthma Inhalers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Asthma Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Asthma Inhalers, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Asthma Inhalers, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Asthma Inhalers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Asthma Inhalers sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Asthma Inhalers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Asthma Inhalers sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Asthma Inhalers in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Asthma Inhalers manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Inhalers sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Asthma Inhalers Product Introduction
1.2 Market by Type
1.2.1 Global Asthma Inhalers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Metered Dose Inhaler (MDI)
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Soft Mist Inhaler (SMI)
1.3 Market by Application
1.3.1 Global Asthma Inhalers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Asthma Inhalers Sales Estimates and Forecasts 2019-2030
2.2 Global Asthma Inhalers Revenue by Region
2.2.1 Global Asthma Inhalers Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Asthma Inhalers Revenue by Region (2019-2024)
2.2.3 Global Asthma Inhalers Revenue by Region (2025-2030)
2.2.4 Global Asthma Inhalers Revenue Market Share by Region (2019-2030)
2.3 Global Asthma Inhalers Sales Estimates and Forecasts 2019-2030
2.4 Global Asthma Inhalers Sales by Region
2.4.1 Global Asthma Inhalers Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Asthma Inhalers Sales by Region (2019-2024)
2.4.3 Global Asthma Inhalers Sales by Region (2025-2030)
2.4.4 Global Asthma Inhalers Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Asthma Inhalers Sales by Manufacturers
3.1.1 Global Asthma Inhalers Sales by Manufacturers (2019-2024)
3.1.2 Global Asthma Inhalers Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma Inhalers in 2023
3.2 Global Asthma Inhalers Revenue by Manufacturers
3.2.1 Global Asthma Inhalers Revenue by Manufacturers (2019-2024)
3.2.2 Global Asthma Inhalers Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Asthma Inhalers Revenue in 2023
3.3 Global Key Players of Asthma Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Asthma Inhalers Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Asthma Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Asthma Inhalers, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Asthma Inhalers, Product Offered and Application
3.8 Global Key Manufacturers of Asthma Inhalers, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Asthma Inhalers Sales by Type
4.1.1 Global Asthma Inhalers Historical Sales by Type (2019-2024)
4.1.2 Global Asthma Inhalers Forecasted Sales by Type (2025-2030)
4.1.3 Global Asthma Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Asthma Inhalers Revenue by Type
4.2.1 Global Asthma Inhalers Historical Revenue by Type (2019-2024)
4.2.2 Global Asthma Inhalers Forecasted Revenue by Type (2025-2030)
4.2.3 Global Asthma Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Inhalers Price by Type
4.3.1 Global Asthma Inhalers Price by Type (2019-2024)
4.3.2 Global Asthma Inhalers Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Asthma Inhalers Sales by Application
5.1.1 Global Asthma Inhalers Historical Sales by Application (2019-2024)
5.1.2 Global Asthma Inhalers Forecasted Sales by Application (2025-2030)
5.1.3 Global Asthma Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Asthma Inhalers Revenue by Application
5.2.1 Global Asthma Inhalers Historical Revenue by Application (2019-2024)
5.2.2 Global Asthma Inhalers Forecasted Revenue by Application (2025-2030)
5.2.3 Global Asthma Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Inhalers Price by Application
5.3.1 Global Asthma Inhalers Price by Application (2019-2024)
5.3.2 Global Asthma Inhalers Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Asthma Inhalers Market Size by Type
6.1.1 US & Canada Asthma Inhalers Sales by Type (2019-2030)
6.1.2 US & Canada Asthma Inhalers Revenue by Type (2019-2030)
6.2 US & Canada Asthma Inhalers Market Size by Application
6.2.1 US & Canada Asthma Inhalers Sales by Application (2019-2030)
6.2.2 US & Canada Asthma Inhalers Revenue by Application (2019-2030)
6.3 US & Canada Asthma Inhalers Market Size by Country
6.3.1 US & Canada Asthma Inhalers Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Asthma Inhalers Sales by Country (2019-2030)
6.3.3 US & Canada Asthma Inhalers Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Asthma Inhalers Market Size by Type
7.1.1 Europe Asthma Inhalers Sales by Type (2019-2030)
7.1.2 Europe Asthma Inhalers Revenue by Type (2019-2030)
7.2 Europe Asthma Inhalers Market Size by Application
7.2.1 Europe Asthma Inhalers Sales by Application (2019-2030)
7.2.2 Europe Asthma Inhalers Revenue by Application (2019-2030)
7.3 Europe Asthma Inhalers Market Size by Country
7.3.1 Europe Asthma Inhalers Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Asthma Inhalers Sales by Country (2019-2030)
7.3.3 Europe Asthma Inhalers Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Asthma Inhalers Market Size
8.1.1 China Asthma Inhalers Sales (2019-2030)
8.1.2 China Asthma Inhalers Revenue (2019-2030)
8.2 China Asthma Inhalers Market Size by Application
8.2.1 China Asthma Inhalers Sales by Application (2019-2030)
8.2.2 China Asthma Inhalers Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Asthma Inhalers Market Size by Type
9.1.1 Asia Asthma Inhalers Sales by Type (2019-2030)
9.1.2 Asia Asthma Inhalers Revenue by Type (2019-2030)
9.2 Asia Asthma Inhalers Market Size by Application
9.2.1 Asia Asthma Inhalers Sales by Application (2019-2030)
9.2.2 Asia Asthma Inhalers Revenue by Application (2019-2030)
9.3 Asia Asthma Inhalers Sales by Region
9.3.1 Asia Asthma Inhalers Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Asthma Inhalers Revenue by Region (2019-2030)
9.3.3 Asia Asthma Inhalers Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Asthma Inhalers Market Size by Type
10.1.1 Middle East, Africa and Latin America Asthma Inhalers Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Asthma Inhalers Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Asthma Inhalers Market Size by Application
10.2.1 Middle East, Africa and Latin America Asthma Inhalers Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Asthma Inhalers Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Asthma Inhalers Sales by Country
10.3.1 Middle East, Africa and Latin America Asthma Inhalers Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Asthma Inhalers Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Asthma Inhalers Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GlaxoSmithKline Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 AstraZeneca Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Boehringer Ingelheim Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Chiesi
11.4.1 Chiesi Company Information
11.4.2 Chiesi Overview
11.4.3 Chiesi Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Chiesi Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chiesi Recent Developments
11.5 Cipla
11.5.1 Cipla Company Information
11.5.2 Cipla Overview
11.5.3 Cipla Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Cipla Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cipla Recent Developments
11.6 3M
11.6.1 3M Company Information
11.6.2 3M Overview
11.6.3 3M Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 3M Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 3M Recent Developments
11.7 Hovione
11.7.1 Hovione Company Information
11.7.2 Hovione Overview
11.7.3 Hovione Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hovione Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hovione Recent Developments
11.8 Mannkind
11.8.1 Mannkind Company Information
11.8.2 Mannkind Overview
11.8.3 Mannkind Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mannkind Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mannkind Recent Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Overview
11.9.3 Mylan Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Mylan Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mylan Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Novartis Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Schering/Merck
11.11.1 Schering/Merck Company Information
11.11.2 Schering/Merck Overview
11.11.3 Schering/Merck Asthma Inhalers Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Schering/Merck Asthma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Schering/Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma Inhalers Industry Chain Analysis
12.2 Asthma Inhalers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma Inhalers Production Mode & Process
12.4 Asthma Inhalers Sales and Marketing
12.4.1 Asthma Inhalers Sales Channels
12.4.2 Asthma Inhalers Distributors
12.5 Asthma Inhalers Customers
13 Market Dynamics
13.1 Asthma Inhalers Industry Trends
13.2 Asthma Inhalers Market Drivers
13.3 Asthma Inhalers Market Challenges
13.4 Asthma Inhalers Market Restraints
14 Key Findings in The Global Asthma Inhalers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Asthma Inhalers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 143
USD 3950.00
(Single User License)
The global Asthma Inhalers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 125
USD 2900.00
(Single User License)
The global Asthma Inhalers market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 98
USD 4250.00
(Single User License)
The global Asthma Inhalers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 151
USD 4900.00
(Single User License)
The global market for Asthma Inhalers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 125
USD 3950.00
(Single User License)
The global market for Asthma Inhalers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
The global Asthma Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
The global market for Asthma Inhalers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 143
The global Asthma Inhalers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 125
The global Asthma Inhalers market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 98
The global Asthma Inhalers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 151
The global market for Asthma Inhalers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 125
The global market for Asthma Inhalers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 89
The global Asthma Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now